Work

Amyloid formation of mutated Alzheimer's Aβ 16–36 residues peptide and application in toxic lead and uranium ion binding

Year: 2025

Type: article

Abstract: A glutamic acid and arginine mutated 21 amino acid residue containing peptide developed based on Alzheimer's Aβ peptide shows propensity to form amyloid nanostructures which are used as biocompatible materials for toxic lead and uranium binding.

Source: Nanoscale Advances

DOI: 10.1039/d5na00228a

Authors: Aishwarya Natarajan, Late Ramakrishna Vadrevu, Aruna Jyothi Kora, Krishnan Rangan

Institutions: Birla Institute of Technology and Science - Hyderabad Campus, Birla Institute of Technology and Science, Pilani, Bhabha Atomic Research Centre, Homi Bhabha National Institute, National Centre for Compositional Characterisation of Materials

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

Open Access status: gold

Estimated APC paid: $1,962

Funders: Department of Atomic Energy, Government of India, Board of Research in Nuclear Sciences